Lipid Resource Center


		• Cardiovascular disease in women: a guide to risk factor screening, prevention, and management. • VHA/DoD clinical practice guideline for the management of dyslipidemia in primary care.


		• Atherosclerosis • Coronary Artery Atherosclerosis • Hypercholesterolemia, Familial • Hypercholesterolemia, Polygenic • Hypertriglyceridemia • View All Lipid Articles


		• Aorta with an Ulcerated Plaque • Atherosclerotic Disease of the Carotid Artery • Coronary Artery Stenosis • Lower-Extremity Atherosclerotic Arterial Disease • View All Lipid Multimedia Files


		• Cholesterol Center • High Cholesterol • Understanding Cholesterol-Lowering Medications • Understanding Your Cholesterol Level


		• Coronary disease probability • Low Density Lipoprotein (LDL) • Myocardial infarction probability (Goldman)

Archived Lipid Feature Series


•	Elevated LDL-C Level and Cardiovascular Disease (Series 1, Issue 1)
•	Low HDL and Cardiovascular Disease (Series 1, Issue 2)
•	Review of the Statin Safety Profile With the Focus on Hepatotoxicity and Rhabdomyolysis (Series 1, Issue 3)
•	Hypertriglyceridemia and Cardiovascular Disease (Series 1, Issue 4)
•	Metabolic Syndrome and Cardiovascular Disease (Series 1, Issue 5)
•	Diabetes and Cardiovascular Disease (Series 1, Issue 6)
•	Hypercholesterolemia and Cardiovascular Disease (Series 1, Issue 7)
•	Statins: cardiovascular disease regression and plaque stabilization (Series 1, Issue 8)
•	New ATP III Lipid Guidelines Update for Patients at High Risk for Cardiovascular Events (Series 1, Issue 9)
•	Dyslipidemia and Metabolic Syndrome (Series 1, Issue 10)
•	Lipoprotein(a) and Cardiovascular Disease (Series 1, Issue 11)
•	Need for More Aggressive Statin Use in Various Ethnic Groups: Latino, Asian, and African American Populations (Series 1, Issue 12)
•	LDL Reduction Patterns With Statin Therapy in High-Risk Patients (Series 1, Issue 13)
•	Statins: Clinical Pharmacology and Use in Special Populations (Series 1, Issue 14)
•	The Effect of HDL Levels on Cardiovascular Disease (Series 2, Issue 1)
•	Role of Diet and Exercise in Treatment of Hyperlipidemia (Series 2, Issue 2)
•	Pharmacokinetics and Pharmacodynamics of Statins (Series 2, Issue 3)
•	Review of the ATP III Lipid Guidelines Update for Patients at High Risk (Series 2, Issue 4)
•	Need for More Aggressive Statin Use in High-Risk Ethnic Groups (Series 2, Issue 5)
•	The Effect of Elevated LDL Levels on Cardiovascular Disease (Series 2, Issue 6)
•	Role of Diabetes as Comorbidity in Cardiovascular Disease (Series 2, Issue 7)
•	Statins: Cardiovascular Regression and Plaque Stabilization (Series 2, Issue 8)
•	New Associations Between Metabolic Syndrome and Cardiovascular Disease (Series 2, Issue 9)
•	The Role of Hypertriglyceridemia in the Development of Cardiovascular Disease (Series 2, Issue 10)
•	Hypercholesterolemia and CVD (Series 2, Issue 11)

We subscribe to the
HONcode principles of the
Health On the Net Foundation

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.